{"url_path":"/sec/advb/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1941029/0001213900-26-057226-index.html","accession_number":"0001213900-26-057226","cik":"0001941029","ticker":"ADVB","issuer_name":"Advanced Biomed Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1941029/0001213900-26-057226-index.html","primary_entity_key":"0001941029","primary_entity_name":"Advanced Biomed Inc."},"word_count":929,"has_tables":true,"body_markdown":"**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n** **\n\n**FORM 10-Q**\n\n** **\n\n☒\n**QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\nFor the quarterly period ended March 31, 2026\n\n \n\nOR\n\n \n\n☐\n**TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\nFor the transition period from                          \nto                          \n\n \n\nCommission file number: **001-42548**\n\n \n\n**Advanced Biomed Inc**\n\n(Exact name of registrant as specified in its charter)\n\n \n\n**Nevada**   **87-2177170**\n\n(State or other jurisdiction of\n\nincorporation or organization)   (I.R.S. Employer\n\nIdentification No.)\n\n \n\n**No. 689-85 Xiaodong Road, Yongkang\nDistrict**\n\n**Tainan City, Taiwan**\n\n(Address of principal executive offices)\n\n \n\n**886-6-3121716**\n\n(Registrant’s telephone number, including\narea code)\n\n \n\n**Securities registered pursuant to Section 12(b)\nof the Act:**\n\n \n\n**Title of Each Class:**   **Trading Symbol(s):**   **Name of Each Exchange on Which Registered:**\n\nCommon Stock, par value $0.001 per share   ADVB   The Nasdaq Stock Market LLC\n\n \n\nIndicate by check mark whether the registrant\n(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months\n(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements\nfor the past 90 days. Yes ☒ No ☐\n\n \n\nIndicate by check mark whether the registrant\nhas submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405\nof this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes\n☒ No ☐\n\n \n\nIndicate by check mark whether the registrant\nis a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.\nSee the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”\nand “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n \n\nLarge accelerated filer ☐ Accelerated filer ☐\n\nNon-accelerated filer ☒ Smaller reporting company ☒\n\n    Emerging growth company ☒\n\n \n\nIf an emerging growth company, indicate by check\nmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting\nstandards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\nIndicate by check mark whether the registrant\nis a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐\nNo ☒ \n\n \n\nAs of March 31, 2026, Advanced Biomed Inc had\n1,382,133 shares of outstanding Common Stock, par value $0.001 per share.\n\n \n\n \n\n \n\n \n\n \n\n \n\n**ADVANCED BIOMED INC**\n\n**FORM 10-Q**\n\n** **\n\n**TABLE OF CONTENTS** \n\n** **\n\n \n \n**Page**\n\n[PART I](#a_001)\n[FINANCIAL INFORMATION](#a_001)\n1\n\n[Item 1.](#a_002)\n[Financial Statements](#a_002)\n1\n\n[Item 2.](#a_003)\n[Management’s Discussion and Analysis of Financial Condition and Results of Operations](#a_003)\n27\n\n[Item 3.](#a_004)\n[Quantitative and Qualitative Disclosure About Market Risk](#a_004)\n41\n\n[Item 4.](#a_005)\n[Controls and Procedures](#a_005)\n41\n\n \n \n \n\n[PART II](#a_006)\n[OTHER INFORMATION](#a_006)\n42\n\n[Item 1.](#a_007)\n[Legal Proceedings](#a_007)\n42\n\n[Item 1A.](#a_008)\n[Risk Factors](#a_008)\n42\n\n[Item 2.](#a_009)\n[Unregistered Sales of Equity Securities and Use of Proceeds](#a_009)\n42\n\n[Item 3.](#a_010)\n[Defaults Upon Senior Securities](#a_010)\n42\n\n[Item 4.](#a_011)\n[Mine Safety Disclosures](#a_011)\n42\n\n[Item 5.](#a_012)\n[Other Information](#a_012)\n42\n\n[Item 6.](#a_013)\n[Exhibits](#a_013)\n42\n\n[Signature](#a_014)\n43\n\n \n\ni\n\n \n\n \n\n**Forward-Looking Statements**\n\n \n\nThe following discussion and analysis of our financial\ncondition, results of operations and notes to the unaudited interim condensed consolidated financial statements included herein contains\nforward-looking statements that reflect our plans, beliefs, expectations and current views with respect to, among other things, future\nevents and financial performance. Our actual results could differ materially from the forward-looking statements included herein. Statements\nregarding our future and projections relating to revenue, cost of sales, expenses, costs, income (loss), and potential growth opportunities\nare typical of such statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed\nin “Risk Factors” in our annual report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”)\non October 8, 2025.\n\n \n\nThe following contains forward-looking statements\nwithin the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as\namended, relating to our operations, results of operations and other matters that are based on our current expectations, estimates, assumptions\nand projections. The forward-looking statements appear in a number of places in the section titled “Management’s Discussion\nand Analysis of Financial Condition and Results of Operations”. Forward-looking statements are based on our management’s beliefs\nand assumptions and on information currently available to our management. In some cases, you can identify forward-looking statements by\nthe words “may,” “might,” “will,” “could,” “would,” “should,”\n“expect,” “is/are likely to,” “intend,” “plan,” “objective,” “anticipate,”\n“believe,” “estimate,” “predict,” “potential,” “target,” “continue”\nand “ongoing,” or the negative of these terms or other comparable terminology intended to identify statements about the future.\nThe forward-looking statements and opinions are based upon current expectations and, while we believe such information forms a reasonable\nbasis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have\nconducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements involve known and\nunknown risks, uncertainties and other important factors that may cause our actual results, levels of activity, performance or achievements\nto be materially different from the information expressed or implied by these forward-looking statements. We caution that you should not\nplace undue reliance on any of our forward-looking statements. We undertake no obligation to update forward-looking statements to reflect\ndevelopments or information obtained after the date hereof and disclaim any obligation to do so except as required by applicable laws.\n\n \n\nii\n\n \n\n \n\n**PART I. FINANCIAL INFORMATION**"}